Trial intelligence / Profile preview

Comparison of Anahil Plus and ibuprofen for pain relief after root canal treatment

IRCT20220517054898N1Phase 2Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of ibuprofen in irreversible pulpitis and odontalgia (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Postoperative pain intensity. Started Aug 2023; status: completed.

02

Drugs

ibuprofen
03

Conditions

irreversible pulpitisodontalgia

Beyond the preview

Go deeper on IRCT20220517054898N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220517054898N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call